GLYCEROL SOLVATE FORMS OF (R) - 2 - [ [ [3 -METHYL -4 (2,2, 2 - TRIFLUOROETHOXY) PYRIDIN- 2 - YL] METHYL] SULPHINYL] - 1H - BEN ZIMIDAZOLE

The present invention relates to novel crystalline forms of (R)-2-[[[3-methyl-4(2,2,2- trifluoroethoxy)pyridin-2-yl]methyl]sulphinyl]-lH-benzimidazole (Formula 1), to processes for their preparation, to pharmaceutical compositions comprising the same and to the use of such crystalline forms for the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SRINIVAS, PATHI L, MALHOTRA, GEENA, RAMASUBBU, CHANDRASEKARAN, KANATHALA, SHASHI REKHA, RAO, DHARMARAJ RAMACHANDRA, GANGRADE, MANISH, JAYACHANDRAN, JENNET, PURANDARE, SHRINIVAS MADHUKAR, KANKAN, RAJENDRA NARAYANRAO
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to novel crystalline forms of (R)-2-[[[3-methyl-4(2,2,2- trifluoroethoxy)pyridin-2-yl]methyl]sulphinyl]-lH-benzimidazole (Formula 1), to processes for their preparation, to pharmaceutical compositions comprising the same and to the use of such crystalline forms for the treatment of gastrointestinal (GI) disorders. La présente invention concerne des nouvelles formes cristallines de (R)-2-[[[3-methyl-4(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphinyl]-lH-benzimidazole (Formule 1), des procédés pour leur préparation, des compositions pharmaceutiques les comprenant et l'utilisation de telles formes cristallines pour le traitement de troubles gastro-intestinaux (GI).